X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (180) 180
index medicus (141) 141
male (133) 133
female (113) 113
middle aged (98) 98
endocrinology & metabolism (90) 90
diabetes (78) 78
adult (69) 69
aged (57) 57
risk factors (48) 48
atherosclerosis (45) 45
type 2 diabetes (42) 42
cardiac & cardiovascular systems (40) 40
oxidative stress (39) 39
animals (38) 38
insulin (38) 38
research (33) 33
blood glucose - metabolism (32) 32
endothelium (32) 32
metabolic syndrome (32) 32
cardiovascular disease (31) 31
diabetes mellitus (31) 31
glucose (31) 31
insulin resistance (29) 29
cardiovascular diseases (27) 27
endothelial dysfunction (27) 27
internal medicine (27) 27
physiological aspects (26) 26
diabetes mellitus, type 2 - drug therapy (25) 25
endothelial progenitor cells (25) 25
insulin-resistance (25) 25
medicine & public health (25) 25
analysis (24) 24
insulin - blood (24) 24
cardiovascular (23) 23
inflammation (23) 23
metabolism (23) 23
research article (23) 23
stem cells (23) 23
diabetes mellitus, type 2 - complications (22) 22
obesity (22) 22
health aspects (21) 21
hypertension (21) 21
medicine (21) 21
diabetes mellitus, type 2 - blood (20) 20
disease (20) 20
metabolic diseases (20) 20
risk (20) 20
cardiovascular-disease (19) 19
care and treatment (19) 19
diabetes mellitus, type 2 - physiopathology (19) 19
flow cytometry (19) 19
nutrition & dietetics (19) 19
case-control studies (18) 18
medicine, research & experimental (18) 18
cardiovascular risk (17) 17
dextrose (17) 17
mellitus (17) 17
mice (17) 17
peripheral vascular disease (17) 17
dysfunction (16) 16
endocrinology (16) 16
hyperglycemia (16) 16
pharmacology & pharmacy (16) 16
cells (15) 15
glucose - metabolism (15) 15
patients (15) 15
time factors (15) 15
cardiovascular system (14) 14
diabetes mellitus, type 2 - metabolism (14) 14
diabetics (14) 14
kinetics (14) 14
nitric oxide (14) 14
prognosis (14) 14
rats (14) 14
activation (13) 13
aged, 80 and over (13) 13
apoptosis (13) 13
mortality (13) 13
physiology (13) 13
progenitor cells (13) 13
science (13) 13
blood glucose - drug effects (12) 12
cardiovascular diseases - etiology (12) 12
cells, cultured (12) 12
cholesterol (12) 12
complications (12) 12
complications and side effects (12) 12
diet (12) 12
heart (12) 12
hypoglycemic agents - therapeutic use (12) 12
multidisciplinary sciences (12) 12
peripheral-blood (12) 12
proteins (12) 12
adolescent (11) 11
bone marrow (11) 11
cardiology (11) 11
cross-sectional studies (11) 11
diagnosis (11) 11
endothelium, vascular - physiopathology (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 05/2008, Volume 28, Issue 5, pp. 997 - 1004
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 07/2010, Volume 33, Issue 7, pp. 1607 - 1609
OBJECTIVE - Vasculoprotective endothelial progenitor cells (EPCs) are regulated by stromal-derived factor-1 alpha (SDF-1 alpha) and are reduced in type 2... 
SDF-1 | NATURAL-HISTORY | MOBILIZATION | ENDOCRINOLOGY & METABOLISM | Original Research
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 02/2015, Volume 17, Issue 2, pp. 107 - 115
The prevalence of type 2 diabetes mellitus (T2DM) among elderly people is increasing. Often associated with disabilities/comorbidities, T2DM lowers the chances... 
frailty | comorbidities | hypoglycaemia | incretin therapy | diabetes treatment | renal impairment | Incretin therapy | Frailty | Diabetes treatment | Renal impairment | Comorbidities | Hypoglycaemia | INSULIN SECRETAGOGUES | GLYCEMIC CONTROL | DPP-4 INHIBITOR | COGNITIVE FUNCTION | VASCULAR-DISEASE | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | POOLED ANALYSIS | BRAIN MITOCHONDRIAL-FUNCTION | SEVERE RENAL IMPAIRMENT | METFORMIN MONOTHERAPY | Cardiovascular Diseases - etiology | Cardiovascular Diseases - prevention & control | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Glycated Hemoglobin A - drug effects | Body Weight - drug effects | Diabetic Angiopathies - blood | Evidence-Based Medicine | Pyrrolidines - therapeutic use | Blood Glucose - drug effects | Hypoglycemia - prevention & control | Diabetes Mellitus, Type 2 - blood | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - blood | Quality of Life | Aged | Diabetic Angiopathies - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Adamantane - analogs & derivatives | Nitriles - therapeutic use | Practice Guidelines as Topic | Diabetics | Hypoglycemic agents | Safety and security measures | Diabetes | Diabetes in old age | Drug therapy | Older people
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 05/2010, Volume 33, Issue 5, pp. 1097 - 1102
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 04/2014, Volume 20, Issue 14, pp. 2387 - 2394
Dipeptidyl peptidases 4 (DPP4) inhibitors are a new class of oral anti-hyperglycemic drugs for the treatment of type 2 diabetes (T2DM). They are also called... 
Journal Article
Journal Article